Altimmune logo
Altimmune ALT
$ 1.33 -5.67%
report update icon

Quarterly report 2026-Q3
added 11-12-2026

Altimmune Market Cap | ALT

As of November 22, 2026 Altimmune has a market cap of $ 117 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Altimmune

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
318 M 463 M 473 M 593 M 333 M 472 M 23.2 M 9.3 M 23.4 M 5.66 K 3.31 M 4.03 M 443 K 362 K 189 K - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
593 M 5.66 K 181 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
SIGA Technologies SIGA Technologies
SIGA
404 M $ 2.4 -9.06 % $ 172 M usaUSA
Catabasis Pharmaceuticals, Inc. Catabasis Pharmaceuticals, Inc.
CATB
80.6 M - -6.97 % $ 657 M usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
1.45 B $ 7.56 0.4 % $ 351 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
1.25 B $ 28.3 0.68 % $ 1.32 B usaUSA
China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc.
CBPO
4.56 B - 1.68 % $ 4.65 B chinaChina
Sol-Gel Technologies Ltd. Sol-Gel Technologies Ltd.
SLGL
203 M $ 55.64 2.88 % $ 155 M israelIsrael
Syndax Pharmaceuticals Syndax Pharmaceuticals
SNDX
1.73 B $ 8.71 -4.16 % $ 755 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
467 M $ 3.47 -6.48 % $ 371 M usaUSA
Pliant Therapeutics Pliant Therapeutics
PLRX
81.6 M $ 0.59 -4.42 % $ 36.2 M usaUSA
Jaguar Health Jaguar Health
JAGX
956 K $ 0.24 -27.06 % $ 560 K usaUSA
Arvinas Arvinas
ARVN
869 M $ 6.41 -4.9 % $ 454 M usaUSA
Cerus Corporation Cerus Corporation
CERS
496 M $ 1.86 -2.37 % $ 355 M usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
3.2 B $ 20.87 -0.36 % $ 2.06 B usaUSA
Inhibrx Inhibrx
INBX
1.75 B $ 68.81 -7.43 % $ 3.24 B usaUSA
Scholar Rock Holding Corporation Scholar Rock Holding Corporation
SRRK
5.09 B $ 48.09 -4.54 % $ 5.52 B usaUSA
Revolution Medicines Revolution Medicines
RVMD
19.6 B $ 161.01 0.99 % $ 30.6 B usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
89.6 M $ 3.29 0.15 % $ 152 M israelIsrael
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
521 M - - $ 459 M usaUSA
Legend Biotech Corporation Legend Biotech Corporation
LEGN
6.91 B $ 15.21 -5.53 % $ 5.61 B usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
931 M $ 2.04 -0.73 % $ 281 M usaUSA
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
1.14 M $ 2.67 2.9 % $ 1.81 M chinaChina
Krystal Biotech Krystal Biotech
KRYS
8.46 B $ 308.83 -2.21 % $ 8.94 B usaUSA
Kura Oncology Kura Oncology
KURA
735 M $ 6.91 -6.05 % $ 606 M usaUSA
Inhibikase Therapeutics Inhibikase Therapeutics
IKT
160 M $ 1.31 0.38 % $ 129 M usaUSA
Protara Therapeutics Protara Therapeutics
TARA
245 M $ 2.28 -5.21 % $ 97.7 M usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
198 M $ 0.25 -5.3 % $ 41.7 M usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
98.5 M $ 1.76 2.63 % $ 82.5 M usaUSA
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
318 M $ 9.66 -3.5 % $ 763 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
27.5 M $ 2.66 -0.37 % $ 32.8 M usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
32.8 M - -5.76 % $ 99.8 M usaUSA
Innoviva Innoviva
INVA
1.62 B $ 18.42 0.03 % $ 1.24 B usaUSA
BioCardia BioCardia
BCDA
8.07 M $ 0.77 -0.08 % $ 5.13 M usaUSA
Bio-Techne Corporation Bio-Techne Corporation
TECH
11.3 B $ 72.69 -0.01 % $ 11.3 B usaUSA
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
196 M - 0.11 % $ 419 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
29.4 B $ 1.52 -8.16 % $ 9.72 B australiaAustralia
Shineco, Inc. Shineco, Inc.
TYHT
13.2 M - -3.90 % $ 97.2 M chinaChina
ORIC Pharmaceuticals ORIC Pharmaceuticals
ORIC
1.02 B $ 7.34 -4.68 % $ 644 M usaUSA
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
MLND
2.5 M - -5.36 % $ 20.2 M usaUSA
Certara Certara
CERT
1.08 B $ 10.56 -1.12 % $ 1.69 B usaUSA
Intec Pharma Ltd Intec Pharma Ltd
NTEC
16.1 M - -12.45 % $ 17.7 M israelIsrael
Anika Therapeutics Anika Therapeutics
ANIK
214 M $ 13.26 -0.15 % $ 190 M usaUSA
Aprea Therapeutics Aprea Therapeutics
APRE
4.97 M $ 0.23 -52.81 % $ 1.5 M usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
178 M $ 2.68 -4.63 % $ 171 M usaUSA
Processa Pharmaceuticals Processa Pharmaceuticals
PCSA
4.14 M $ 1.59 -5.92 % $ 2.08 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
3.75 B $ 63.61 -2.11 % $ 6.61 B usaUSA
Progenity, Inc. Progenity, Inc.
PROG
339 M - -3.47 % $ 164 M usaUSA
Genprex Genprex
GNPX
1.65 M $ 1.46 -12.87 % $ 1.36 M usaUSA
Strongbridge Biopharma plc Strongbridge Biopharma plc
SBBP
151 M - 1.52 % $ 136 M usaUSA
Nektar Therapeutics Nektar Therapeutics
NKTR
1.09 B $ 30.23 -7.1 % $ 510 M usaUSA
Innate Pharma S.A. Innate Pharma S.A.
IPHA
126 M $ 0.87 -7.57 % $ 77.9 M franceFrance